Legorreta Pablo G. — SEC Form 4 filings
SEC reporting owner CIK 1507678. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-02-06 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 22,617,909 shares, $54,735,340 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: purchase of 22,617,909 shares @ $2.42 ($54,735,340) in PROKIDNEY CORP., filed 2024-06-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PROKIDNEY CORP. (PROK) | Director, 10% owner | 7 | 1 leg · 22,617,909 sh · $54,735,340 | — | 15 |
| Royalty Pharma plc (RPRX) | CEO, Chairman of the Board, Director | 8 | — | — | 13 |
Form 4 filings — Legorreta Pablo G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 65,216 @ $0 · Gift (G): 30,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | PROKIDNEY CORP. (PROK) | Grant/award (A): 135,000 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 143,821 @ $0 | EDGAR |
| 2026-02-13 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 157,828 @ $0 | EDGAR |
| 2025-11-07 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 36,559 @ $0 | EDGAR |
| 2025-08-08 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 21,901 @ $0 · Gift (G): 60,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | PROKIDNEY CORP. (PROK) jointly with Tolerantia, LLC | Conversion (C): 3,823,996 @ $0 · Other (J): 3,823,996 @ $0 · Conversion (C): 3,823,996 (derivative) @ $0 · Conversion (C): 3,823,996 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | PROKIDNEY CORP. (PROK) | Grant/award (A): 125,862 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Royalty Pharma plc (RPRX) | Other (J): 530,348 @ $0 · Grant/award (A): 13,356,742 (derivative) @ $0 · Other (J): 857,138 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | Royalty Pharma plc (RPRX) | Gift (G): 867,180 (derivative) @ $0 · Gift (G): 867,180 (derivative) @ $0 | EDGAR |
| 2025-05-09 | 4 | Royalty Pharma plc (RPRX) | Grant/award (A): 288,352 @ $0 | EDGAR |
| 2025-02-06 | 4 | PROKIDNEY CORP. (PROK) jointly with Tolerantia, LLC | Conversion (C): 532,535 @ $0 · Other (J): 532,535 @ $0 · Conversion (C): 532,535 (derivative) @ $0 · Conversion (C): 532,535 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | PROKIDNEY CORP. (PROK) jointly with Tolerantia, LLC | Purchase (P): 22,617,909 @ $2.42 | EDGAR |
| 2024-06-03 | 4 | PROKIDNEY CORP. (PROK) | Grant/award (A): 62,558 (derivative) @ $0 | EDGAR |
| 2024-02-06 | 4 | PROKIDNEY CORP. (PROK) jointly with Tolerantia, LLC | Conversion (C): 748,952 @ $0 · Other (J): 748,952 @ $0 · Conversion (C): 748,952 (derivative) @ $0 · Conversion (C): 748,952 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1507678 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →